A Case of Clinical Uncertainty Solved: Giant Cell Arteritis with Polymyalgia Rheumatica Swiftly Diagnosed with Long Axial Field of View PET
The clinical presentation of giant cell arteritis (GCA) is often nonspecific. Differentiating GCA from infectious, malignant, or other autoimmune pathology based on signs, symptoms, and laboratory parameters may therefore be difficult. Fluorine-18-fluorodeoxyglucose (<sup>18</sup>F-FDG)...
Main Authors: | Pieter H. Nienhuis, Joyce van Sluis, Johannes H. van Snick, Andor W. J. M. Glaudemans, Sofie Meijering, Elisabeth Brouwer, Riemer H. J. A. Slart |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/12/11/2694 |
Similar Items
-
Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica
by: Kornelis S. M. van der Geest, et al.
Published: (2022-06-01) -
Imaging in polymyalgia rheumatica
by: N. Possemato, et al.
Published: (2018-03-01) -
18F-FDG-PET/CT for polymyalgia rheumatica: agreement and diagnostic accuracy of routine PET scan report vs. standardized PMR PET scores
by: Kornelis S. M. van der Geest, et al.
Published: (2025-03-01) -
Giant cell arteritis: is the clinical spectrum of the disease changing?
by: Miguel Á. González-Gay, et al.
Published: (2019-07-01) -
Low incidence of malignancy in patients with suspected polymyalgia rheumatica or giant cell arteritis, examined with FDG-PET/CT
by: Tanja Fromberg Gorlen, et al.
Published: (2024-02-01)